LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 1097 | 1172 | 3769 | 0.3109 | 0.0280 |
BT-20 | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 1097 | 1223 | 3769 | 0.3244 | 0.0471 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 1 | P22 | 72 | hr | 1097 | 2913 | 3769 | 0.7728 | 0.6795 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 2 | P22 | 72 | hr | 1097 | 2936 | 3769 | 0.7789 | 0.6881 |
BT-20 | Trametinib | 0.37 | uM | LJP5 | 3 | P22 | 72 | hr | 1097 | 2735 | 3769 | 0.7256 | 0.6129 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 1 | M04 | 72 | hr | 1097 | 3207 | 3769 | 0.8508 | 0.7895 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 2 | M04 | 72 | hr | 1097 | 4067 | 3769 | 1.0789 | 1.1113 |
BT-20 | TWS119 | 0.37 | uM | LJP5 | 3 | M04 | 72 | hr | 1097 | 3422 | 3769 | 0.9078 | 0.8700 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 1097 | 3646 | 3769 | 0.9672 | 0.9538 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 1097 | 3558 | 3769 | 0.9439 | 0.9208 |
BT-20 | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 1097 | 3544 | 3769 | 0.9402 | 0.9156 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1097 | 2831 | 3769 | 0.7510 | 0.6488 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1097 | 2882 | 3769 | 0.7646 | 0.6679 |
BT-20 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1097 | 2671 | 3769 | 0.7086 | 0.5889 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 1097 | 2401 | 3769 | 0.6370 | 0.4879 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 1097 | 2239 | 3769 | 0.5940 | 0.4273 |
BT-20 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1097 | 2141 | 3769 | 0.5680 | 0.3906 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 1 | L10 | 72 | hr | 1097 | 1287 | 3769 | 0.3414 | 0.0710 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 2 | L10 | 72 | hr | 1097 | 1303 | 3769 | 0.3457 | 0.0770 |
BT-20 | WYE-125132 | 0.37 | uM | LJP6 | 3 | L10 | 72 | hr | 1097 | 1369 | 3769 | 0.3632 | 0.1017 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 1 | D22 | 72 | hr | 1097 | 1100 | 3769 | 0.2918 | 0.0010 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 2 | D22 | 72 | hr | 1097 | 1120 | 3769 | 0.2971 | 0.0085 |
BT-20 | WZ3105 | 0.37 | uM | LJP5 | 3 | D22 | 72 | hr | 1097 | 1209 | 3769 | 0.3207 | 0.0418 |
BT-20 | XMD11-50 | 0.37 | uM | LJP6 | 1 | P10 | 72 | hr | 1097 | 2346 | 3769 | 0.6224 | 0.4673 |
BT-20 | XMD11-50 | 0.37 | uM | LJP6 | 2 | P10 | 72 | hr | 1097 | 2660 | 3769 | 0.7057 | 0.5848 |